DCF — KADLEC REGIONAL MEDICAL CENTER
Enterprise Value: $-902.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-902.8M
Enterprise Value
$-292.2M
PV of Cash Flows
$-610.6M
PV of Terminal Value
$-983.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $759.8M | $-52.7M | -7.0% | $-84.8M | $-77.1M |
| Year 2 | $782.6M | $-46.4M | -6.0% | $-79.5M | $-65.7M |
| Year 3 | $806.1M | $-39.7M | -5.0% | $-73.9M | $-55.5M |
| Year 4 | $830.2M | $-36.8M | -4.0% | $-71.9M | $-49.1M |
| Year 5 | $855.2M | $-35.8M | -4.0% | $-72.0M | $-44.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-902.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$737.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0743129832596743
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5